Jae Kim
Patrimonio netto: - $ in data 31/07/2026
Patrimonio netto: - $ in data 31/07/2026
Jae B. Kim worked as Vice President-Clinical Development at Alnylam Pharmaceuticals, Inc. from 2016 to 2020.
Served as Chief Medical Officer at Avidity Biosciences, Inc. from 2020 to 2021.
Held the position of Chief Medical Officer at Design Therapeutics, Inc. from 2022 to 2024.
Worked as Chief Medical Officer at Septerna, Inc. from 2024 to 2026.
Completed undergraduate studies at Cornell University.
Earned a doctorate from Weill Cornell Medical College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SEPTERNA, INC. -.--% | 06/02/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
| SEPTERNA, INC. | Direttore Tecnico/Scientifico/R&S | 11/05/2026 |
| DESIGN THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2024 |
| AVIDITY BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 30/08/2021 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Avidity Biosciences, Inc.
Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Design Therapeutics, Inc.
Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
Septerna, Inc.
Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale